ClinicalTrialsFinder

Relapsed or Refractory Lymphoma Clinical Trials in Sanhe

1 recruitingSanhe, China

Showing 1–1 of 1 trials

Recruiting
Phase 1

Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

Relapsed or Refractory Lymphoma
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd18 enrolled1 locationNCT07453446